Pcv112 - Pattern of Use of Antihypertensive Drugs in Two European Countries: Comparison of the Index Therapies and Persistence

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.657
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Long-Term Persistence With Antihypertensive Drugs in New Patients

Journal of Human Hypertension
Internal Medicine
2002English

Treatment-Related Naturalization Premiums in Two European Countries: Evaluation and Comparison

SSRN Electronic Journal
2017English

Comparison of Treatment Outcome of Antihypertensive Drugs in the Management of Pregnancy Induced Hypertension

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2017English

The Reimbursement of Expensive Drugs in Hospitals in Western European Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Comparison of Drug Related Problems Associated With Use of Narrow Therapeutic Index Drugs and Other Drugs in Hospitalized Patients

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2018English

Prior Experience With Cardiovascular Medicines Predicted Longer Persistence in People Initiated to Combinations of Antihypertensive and Lipid-Lowering Therapies: Findings From Two Australian Cohorts

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2018English

Php81 - Comparison of Selected Drugs Prices in Eu Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Assessment of Generic Drug Policy Implementation by Measuring Persistence With Antihypertensive Drug Therapies After Patent Expiry

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Different Countries-Different Paths Extended Comparison of the Introduction of eIDs in Eight European Countries

Identity in the Information Society
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy